Shares of Summit Therapeutics SMMT have soared 689% year to date, significantly outperforming the industry’s 2.5% decline. The stock has outperformed the sector and the S&P 500 during the same period....
Source LinkShares of Summit Therapeutics SMMT have soared 689% year to date, significantly outperforming the industry’s 2.5% decline. The stock has outperformed the sector and the S&P 500 during the same period....
Source Link
Comments